Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

August 30, 2018

Study Completion Date

August 30, 2018

Conditions

Chronic Hepatitis C

Trial Locations (6)

Pharos Centro de Estudios Clin, Cartagena

IPS Medicos Internistas Del Ca I, Manizales

Cic Cali, Santiago de Cali

Fundacion Cardioinfantil, Bogotá

Centro Medico lmbanaco de Cali I, Santiago de Cali

Fundacion Hospitalaria San Vin, Medellín